Possibility for Examination to be Included in the SHI Fee Scale Brings More Certainty for Reimbursement for New Diagnostics in Germany

Possibility for Examination to be Included in the SHI Fee Scale Brings More Certainty for Reimbursement for New Diagnostics in Germany

In the past, the inclusion of new diagnostic tests in the EBM was not transparent, with unclear timelines and requirements and manufacturers were unable to...
Read More
Escalated DRG Payment Model Pilot in China Expected to Pose a Genuine Threat to Innovators

Escalated DRG Payment Model Pilot in China Expected to Pose a Genuine Threat to Innovators

As a critical element of accelerating the healthcare payment reform, the pilot of Diagnosis Related Groups in 30 major cities across China was officially announced in June by state administrations including...
Read More
First Meeting of the Italian Regional Purchasing Centers

First Meeting of the Italian Regional Purchasing Centers

Quality is not anymore limited to the functional and esthetic products features and its handling use. The attention is now focused on the commercialization phase, innovative and efficacy features, profitability and usability of instruction for final users, as well as Eco-friendly features...
Read More
New Independent Medical Review Board for Germany

New Independent Medical Review Board for Germany

For medical device and diagnostic innovators, a planned organizational change in review boards for Germany’s Statutory Health Insurance (SHI) could lead to new opportunities for market access of their products.
Read More
Winter Has Come – Aggressive National Programs To Drive Down Drug Costs

Winter Has Come – Aggressive National Programs To Drive Down Drug Costs

China: 2018 was another eventful year for the pharmaceutical industry, highlighted by the Chinese government’s radical attempts to slash drug prices by the annual national drug price negotiation and along with the introduction of a national procurement program.
Read More
Your Industry
Read More
Our Expertise
Read More

Our clients are global, and so are we.

Based in Boston, our presence extends internationally, with offices in Berlin, Shanghai, and Hong Kong, giving us significant experience and in-market expertise with emerging and established medical device, diagnostics, and pharmaceutical innovators worldwide.

Read More
Our Team

Boston Healthcare consultants bring energy, problem-solving skills and creativity to every client engagement, from strategy development to implementation.

Overview
Global Leadership Team
Who We Are
Global Capabilities

Read More

Our Process

Read More

Contact Us